Whitehawk Therapeutics (WHWK) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Whitehawk Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $2.6M of WHWK stock on the open market.
Get emailed when insiders cluster-buy stocks like WHWK
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
WHWK insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $2.6M | 11 |
| Q1 2026 | — | 0 | $32K | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Whitehawk Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $2.6M. 0 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Apr 17SEC | Scott M. GiacobelloCFO | Sell | 141,600295,224 held (−32%) | $4.13 | $585K | -14.8% | — |
| Apr 17SEC | Scott M. GiacobelloCFO | Sell | 77,000436,824 held (−15%) | $3.86 | $297K | -8.8% | — |
| Apr 15SEC | Bryan BallSee Remarks | Sell | 92,460397,106 held (−19%) | $3.64 | $337K | -3.3% | — |
| Apr 15SEC | Bryan BallSee Remarks | Sell | 26,389489,566 held (−5%) | $3.46 | $91K | +1.7% | — |
| Apr 13SEC | Bryan BallSee Remarks | Sell | 50,000522,551 held (−9%) | $3.57 | $178K | -1.4% | — |
| Apr 13SEC | Bryan BallSee Remarks | Sell | 6,596515,955 held (−1%) | $3.43 | $23K | +2.6% | — |
| Apr 10SEC | David James LennonCEO | Sell | 14,500518,622 held (−3%) | $3.38 | $49K | +4.1% | — |
| Apr 8SEC | David James LennonCEO | Sell | 102,395691,154 held (−13%) | $3.51 | $359K | +0.3% | — |
| Apr 8SEC | David James LennonCEO | Sell | 94,087597,067 held (−14%) | $3.43 | $323K | +2.6% | — |
| Apr 8SEC | David James LennonCEO | Sell | 63,945533,122 held (−11%) | $3.40 | $217K | +3.5% | — |
| Apr 3SEC | David James LennonCEO | Sell | 26,858793,549 held (−3%) | $3.48 | $93K | +1.1% | — |
| Mar 10SEC | David James LennonCEO | Sell | 5,10044,579 held (−10%) | $3.31 | $17K | +6.3% | — |
| Mar 10SEC | Scott M. GiacobelloCFO | Sell | 2,59428,100 held (−8%) | $3.31 | $9K | +6.3% | — |
| Mar 10SEC | Bryan BallSee Remarks | Sell | 1,834206,019 held (−1%) | $3.31 | $6K | +6.3% | — |
Insiders at Whitehawk Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| David James LennonCEO | — | $1.1M | Apr 10, 2026 | — |
| Scott M. GiacobelloCFO | — | $891K | Apr 17, 2026 | — |
| Bryan BallSee Remarks | — | $635K | Apr 15, 2026 | — |
WHWK stock: common questions
Are Whitehawk Therapeutics, Inc. insiders buying WHWK stock?
In the past 12 months, 0 insiders reported open-market purchases of WHWK worth $0.
Are Whitehawk Therapeutics, Inc. insiders selling WHWK stock?
3 insiders reported sales worth $2.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is WHWK's 52-week range?
Over the past year WHWK has traded between $1.97 and $5.10. It last closed at $3.52 on Oct 9, 2026.